The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Diagnosis and management of autoimmune hepatitis
Open accessAbstract
Autoimmune hepatitis is an inflammatory disease of the liver of unknown cause that may progress to liver cirrhosis and end stage liver failure if diagnosis is overlooked and treatment delayed. The clinical presentation is often that of acute hepatitis, sometimes very severe; less frequently, it can be insidious or completely asymptomatic. The disease can affect people of any age and is more common in women; its incidence and prevalence seem to be on the rise worldwide. An abnormal immune response targeting liver autoantigens and inducing persistent and self-perpetuating liver inflammation is the pathogenic mechanism of the disease. A specific set of autoantibodies, increased IgG concentrations, and histological demonstration of interface hepatitis and periportal necrosis are the diagnostic hallmarks of autoimmune hepatitis. Prompt response to treatment with corticosteroids and other immunomodulatory drugs is almost universal and supports the diagnosis. The aims of treatment are to induce and maintain long term remission of liver inflammation. Treatment can often even reverse liver fibrosis, thus preventing progression to advanced cirrhosis and its complications. Most patients need lifelong maintenance therapy, and repeated follow-up in experienced hands improves the quality of care and quality of life for affected patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Simplified criteria for the diagnosis of autoimmune hepatitis
Hennes, E. M., Zeniya, M., Czaja, A. J., Parés, A., Dalekos, G. N., Krawitt, E. L., Bittencourt, P. L., Porta, G., Boberg, K. M., Hofer, H., et al. (2008) · Hepatology · doi:10.1002/hep.22322 · Cited by 1,901
Self-citationDiagnosis and management of autoimmune hepatitis
Manns, M. P., Czaja, A. J., Gorham, J. D., Krawitt, E. L., Mieli-Vergani, G., Vergani, D., & Vierling, J. M. (2010) · Hepatology · doi:10.1002/hep.23584 · Cited by 1,442
EASL Clinical Practice Guidelines: autoimmune hepatitis
(2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.06.030 · Cited by 1,245
Mack, C. L., Adams, D., Assis, D. N., Kerkar, N., Manns, M. P., Mayo, M. J., Vierling, J. M., Alsawas, M., Murad, M. H., & Czaja, A. J. (2020) · Hepatology · doi:10.1002/hep.31065 · Cited by 983 · cited 1×
“64-69 If not properly controlled, however, autoimmune hepatitis can flare up during pregnancy, and this is associated with a high rate of , 4 and immunosuppression with azathioprine should be neither reduced nor suspended, as its teratogenic potential in animals is not observed in humans.”
BackgroundChazouillères, O., Wendum, D., Serfaty, L., Montembault, S., Rosmorduc, O., & Poupon, R. (1998) · Hepatology · doi:10.1002/hep.510280203 · Cited by 746 · cited 1×
“According to the Paris criteria, 70 to identify autoimmune hepatitis overlapping with PBC, two of the following three PBC criteria should be met: serum alkaline phosphatase concentration at least twofold the upper limit of normal or serum γ-glutamyl transferase concentration at least fivefold the…”
BackgroundVergani, D., Alvarez, F., Bianchi, F. B., Cançado, E. L. R., Mackay, I. R., Manns, M. P., Nishioka, M., & Penner, E. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.08.002 · Cited by 446
Deneau, M., Jensen, K. M., Holmen, J., Williams, M. S., Book, L. S., & Guthery, S. L. (2013) · Hepatology · doi:10.1002/hep.26454 · Cited by 233 · cited 1×
“50 Autoimmune hepatitis in children has historically been described as potentially very severe or even fulminant.”
BackgroundKaya, M., Angulo, P., & Lindor, K. D. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80004-5 · Cited by 193
Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis
O'Brien, C., Joshi, S., Feld, J. J., Guindi, M., Dienes, H. P., & Heathcote, E. J. (2008) · Hepatology · doi:10.1002/hep.22380 · Cited by 146
Health-related quality of life, depression, and anxiety in patients with autoimmune hepatitis
Schramm, C., Wahl, I., Weiler-Normann, C., Voigt, K., Wiegard, C., Glaubke, C., Brähler, E., Löwe, B., Lohse, A. W., & Rose, M. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.10.035 · Cited by 128
Cited by
Glycosylation: mechanisms, biological functions and clinical implications
He, M., Zhou, X., & Wang, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01886-1 · Cited by 499
Macrophage polarization: an important role in inflammatory diseases
Luo, M., Zhao, F., Cheng, H., Su, M., & Wang, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1352946 · Cited by 468
Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment
Hwang, S. Y., Danpanichkul, P., Agopian, V., Mehta, N., Parikh, N. D., Abou-Alfa, G. K., Singal, A. G., & Yang, J. D. (2025) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0824 · Cited by 306
Zeng, L., Wang, Y., Huang, Y., Yang, W., Zhou, P., Wan, Y., Tao, K., & Li, R. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02075-5 · Cited by 22
Lin, B., Zhang, H., Zhu, P., Chen, J., Li, D., Zhou, J., Zhang, T., Chen, Q., Tang, C., Song, X., et al. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01607-w · Cited by 5
“Autoimmune hepatitis (AIH) is an obscure in fl ammatory liver disease that may be caused by the interaction of individual genetic susceptibility and environmental factors 1,2 .”
Metadata
- Authors
- Muratori, L., Lohse, A. W., & Lenzi, M.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2023-02-06
- Volume
- 380
- Pages
- e070201
- ISSN
- 1756-1833 (ISSN-L)
- OpenAlex
- W4319296574
- Cited by
- 230
- References
- 12
- FWCI
- 32.56
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Diagnosis and management of autoimmune hepatitis. https://app.cochat.ai/papers/10.1136/bmj-2022-070201
- The paper
- Muratori, L., Lohse, A. W., & Lenzi, M. (2023). Diagnosis and management of autoimmune hepatitis. BMJ. https://doi.org/10.1136/bmj-2022-070201
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.